Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025
Context will present data highlighting the selection of the first-in-human dose of CT-95, using the minimal anticipated biological effect level (“MABEL”) approach, as required for immune agonist drugs ...
Stocks in play: Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. shares T.MDNA are trading up $0.04 at $1.03.
Sheriff: 'Top Dog' Junny dies after battle with cancer; was 'loving and loyal' mascot
Junny, the iconic police bloodhound who befriended children and who was the constant companion of Brevard County Sheriff ...
The Manila Times15h
Starton Therapeutics to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2025
Starton Therapeutics Inc. ("Starton” or the "Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the ...
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ...
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that data from preclinical studies of the Company’s internally ...